In terms of general mechanisms, the mechanism of anti-TNF biologic agents in treating IBD is to suppress inflammation via neutralizing and decreasing of TNF levels and to bind with TNF receptors in the inflamed mucosa and to induce mucosal cell apoptosis. This evidence concerns the gene TNF and inflammatory bowel disease.